Company profilePharmaceutical#246 of 1,318 in Pakistan✓ No DRAP alerts

Reign Pharmaceuticals PCSIR - KLC (Pvt.) Ltd.

Pharmaceutical company · 75 brands · 56 molecules

75 registered products 28 pharmaceutical brands 56 distinct molecules 0 DRAP alerts

Company overview

75
registered products
28
pharmaceutical brands
56
distinct molecules
0
therapeutic classes
0
DRAP alerts

Reign Pharmaceuticals PCSIR - KLC (Pvt.) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 75 product registrations across 56 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Reign

38 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

37
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202537

Top molecules by brand count

Azithromycin3 brands
Cefixime3 brands
Omeprazole2 brands
Fluconazole ...... 150 Mg2 brands
Artemether2 brands
Chloroquine2 brands
Levofloxacin2 brands
Fluconazole2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official78 products · Rs 19.03 – Rs 3,698.06
Median across source: Rs 323.14

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.27 shared molecules
HIGH - Q INTERNATIONAL25 shared molecules
NEUTRO PHARMA (PVT) LTD.25 shared molecules
EPHARM LABORATORIES24 shared molecules
MEDISAVE PHARMACEUTICALS24 shared molecules
Glitz Pharma24 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SEMOS PHARMACEUTICALS (PVT) LTD. holds 41 molecules not in this portfolio
AmodiaquineAmodiaquine 150MgArtesunateBisacodylBuprenorphineCeftazidime
BIO LABS (PVT) LTD. holds 122 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAtorvastatin
SHAIGAN PHARMACEUTICALS (PVT) LTD. holds 123 molecules not in this portfolio
AlbendazoleAmikacinAmlodipineAmlodipine BasylateAspirinBetamethasone

Get the full profile for Reign

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.